البحث عن طبيب

Paras H. Shah, M.D.

  1. Oncologist
  2. Urologist

المنشورات

  1. Khanna A, Antolin A, Bar O, Ben-Ayoun D, Zohar M, Boorjian SA, Frank I, Shah P, Sharma V, Thompson RH, Wolf T, Asselmann D, Tollefson M. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence. J Urol. 2024 Apr; 211 (4):575-584 Epub 2024 Jan 24
    View PubMed
  2. Mian AH, Tollefson MK, Shah P, Sharma V, Mian A, Thompson RH, Boorjian SA, Frank I, Khanna A. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. J Clin Med. 2024 Jan 9; 13 (2) Epub 2024 Jan 09
    View PubMed
  3. Durant AM, Whitney MA, Chang YH, Larson MA, Shah PH, Lyon TD, Humphreys MR, Etzioni DA, Tyson MD 2nd. Surgical Site Infections in Open and Laparoscopic Operations in Rooms With Open-floor Drainage Systems. Urol Pract. 2023 Nov; 10 (6):622-629 Epub 2023 July 27
    View PubMed
  4. Nabavizadeh R, Rodrigues Pessoa R, Dumbrava MG, Packiam VT, Thapa P, Tarrell R, Tollefson MK, Jeffrey Karnes R, Frank I, Khanna A, Shah P, Sharma V, Boorjian SA. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series. Urology. 2023 Nov; 181:162-166 Epub 2023 Sept 07
    View PubMed
  5. Rodrigues Pessoa R, Nabavizadeh R, Shah P, Frank I, Tollefson M, Sharma V, Rangel LJ, Cheville JC, Karnes RJ, Boorjian SA. Relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Sep 15 Epub 2023 Sept 15
    View PubMed
  6. Myers A, Frank I, Shah PH, Tarrell RF, Baird B, Dora C, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA, Lyon TD. Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy. J Urol. 2023 Mar; 209 (3):525-531 Epub 2022 Nov 29
    View PubMed
  7. Avulova S, Benidir T, Cheville JC, Packiam VT, Shah P, Frank I, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Kulkarni G, Boorjian SA. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. Arch Pathol Lab Med. 2023 Feb 1; 147 (2):202-207
    View PubMed
  8. Britton CJ, Gottlich HC, Tarrell RF, Thapa P, Joyce DD, Shah PH, Sharma V, Boorjian SA, Frank I, Potretzke AM. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy. Urology. 2023 Feb; 172:149-156 Epub 2022 Nov 25
    View PubMed
  9. Murphy N, Shih AJ, Shah P, Yaskiv O, Khalili H, Liew A, Lee AT, Zhu XH. Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer. Oncotarget. 2022 Nov 2; 13:1188-1200 Epub 2022 Nov 02
    View PubMed
  10. Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol. 2022 Jan; 40 (1):13.e9-13.e18 Epub 2021 Nov 06
    View PubMed
  11. Khanna A, Zganjar A, Lyon T, Shah P, Tollefson MK, Karnes RJ, Tarrell R, Thapa P, Thompson RH, Frank I, Boorjian SA. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy. J Urol. 2021 Oct; 206 (4):970-977 Epub 2021 May 25
    View PubMed
  12. Lyon TD, Frank I, Tollefson MK, Tarrell RF, Shah PH, Thompson RH, Karnes RJ, Boorjian SA. Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy. Urol Oncol. 2021 Jun; 39 (6):370.e1-370.e8 Epub 2020 Dec 08
    View PubMed
  13. Lyon TD, Henry MR, Shah PH, Boorjian SA, Tollefson MK, Frank I. Development of a technique for evaluating the presence of malignant cells in prostatic fluid during robotic prostatectomy. Urol Oncol. 2021 Mar; 39 (3):192.e1-192.e6 Epub 2020 Aug 29
    View PubMed
  14. Ahmed ME, Andrews JR, Alamiri J, Higa J, Haloi R, Alom M, Motterle G, Joshi V, Shah PH, Jeffrey Karnes R, Kwon E. Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes. Prostate. 2020 Oct; 80 (14):1216-1222 Epub 2020 July 31
    View PubMed
  15. Leibovich BC, Lohse CM, Cheville JC, Potretzke TA, Tsivian M, Shah PH, Boorjian SA, Thompson RH, Lyon TD. Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? Kidney Cancer. 2020; 4(2):111-115.
  16. Waingankar N, Martini A, Griffiths L, Shah P, Paulucci DJ, Kotamarti S, Gul Z, Elmasri M, Yaskiv O, Haines K, Lerner S, Vira M, Kavoussi LR, Tewari AK, Kapoor DA, Olsson CA. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential. Urol Oncol. 2020 Mar; 38 (3):78.e15-78.e21 Epub 2019 Dec 01
    View PubMed
  17. Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era. J Urol. 2020 Feb; 203 (2):275-282 Epub 2019 Aug 08
    View PubMed
  18. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. AUTHOR REPLY. Urology 2020 Feb; 136:111
    View PubMed
  19. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy. Urology. 2020 Feb; 136:105-111 Epub 2019 Nov 09
    View PubMed
  20. Shih AJ, Murphy N, Kozel Z, Shah P, Yaskiv O, Khalili H, Liew A, Kavoussi L, Hall S, Vira M, Zhu XH, Lee AT. Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas. Front Oncol. 2020; 10:1383 Epub 2020 Aug 11
    View PubMed
  21. Welch BT, Shah PH, Thompson RH, Atwell TD. The current status of thermal ablation in the management of T1b renal masses. Int J Hyperthermia. 2019 Oct; 36 (2):31-36
    View PubMed
  22. Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease. World J Urol. 2019 Aug; 37 (8):1605-1613 Epub 2018 Nov 03
    View PubMed
  23. Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA. Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. J Urol. 2019 Jul; 202 (1):69-75 Epub 2019 June 07
    View PubMed
  24. Lyon TD, Frank I, Takahashi N, Boorjian SA, Moynagh MR, Shah PH, Tarrell RF, Cheville JC, Viers BR, Tollefson MK. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2019 Jun; 17 (3):216-222.e5 Epub 2019 Mar 25
    View PubMed
  25. Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK. Comprehensive characterization of perioperative reoperation following radical cystectomy. Urol Oncol. 2019 Apr; 37 (4):292.e11-292.e17 Epub 2019 Jan 22
    View PubMed
  26. Samson P, Waingankar N, Shah P, Han J. Practice Patterns of Academic Urologists for Evaluating Microscopic Hematuria-How Well are We Following the Guidelines? Urol Pract. 2019 Mar; 6 (2):86-92 Epub 2018 May 15
    View PubMed
  27. Shah PH, Patel VR, Moreira DM, George AK, Alom M, Kozel Z, Joshi V, Ben-Levi E, Villani R, Yaskiv O, Kavoussi LR, Vira M, Olsson CO, Rastinehad AR. Implementation of multiparametric magnetic resonance imaging technology for evaluation of patients with suspicion for prostate cancer in the clinical practice setting. BJU Int. 2019 Feb; 123 (2):239-245 Epub 2018 Sept 14
    View PubMed
  28. Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma. BJU Int. 2019 Feb; 123 (2):270-276 Epub 2018 Sept 09
    View PubMed
  29. Shah P, Patel VR, Kozel Z, Vira M, Myers A, Kaplan-Marans E, Yaskiv O, Kavoussi LR, Richstone L. Laparoscopic Completion Nephrectomy for Local Surgical Bed Recurrence After Partial Nephrectomy: An Analysis of Procedural Complexity and Feasibility. J Endourol. 2018 Dec; 32 (12):1114-1119
    View PubMed
  30. Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018 Nov; 36 (11):499.e1-499.e7 Epub 2018 Sept 15
    View PubMed
  31. Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. The Association of Aspirin Use with Survival Following Radical Cystectomy. J Urol. 2018 Nov; 200 (5):1014-1021 Epub 2018 May 30
    View PubMed
  32. Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018 Nov; 200 (5):981-988 Epub 2018 May 22
    View PubMed
  33. Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018 Sep; 200 (3):520-527 Epub 2018 Apr 27
    View PubMed
  34. Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA. Temporal trends in venous thromboembolism after radical cystectomy. Urol Oncol. 2018 Aug; 36 (8):361.e15-361.e21 Epub 2018 June 07
    View PubMed
  35. Samson P, Waingankar N, Shah P, Friedman D, Kavoussi L, Han J. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria. Urol Oncol. 2018 Jan; 36 (1):10.e1-10.e6 Epub 2017 Oct 05
    View PubMed
  36. Ng AM, Shah PH, Kavoussi LR. Laparoscopic Partial Nephrectomy: A Narrative Review and Comparison with Open and Robotic Partial Nephrectomy. J Endourol. 2017 Oct; 31 (10):976-984 Epub 2017 Sept 22
    View PubMed
  37. Shah PH, Moreira DM, Patel VR, Gaunay G, George AK, Alom M, Kozel Z, Yaskiv O, Hall SJ, Schwartz MJ, Vira MA, Richstone L, Kavoussi LR. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a. J Urol. 2017 Aug; 198 (2):289-296 Epub 2017 Mar 06
    View PubMed
  38. Celtik KE, Shah PH, Patel VR, Moreira DM, George AK, Iacovelli V, Alom M, Ng A, Herati A, Salami SS, Bierwiler H, Schwartz MJ, Richstone L, Steckel J, Vira MA, Kavoussi LR. Active surveillance for incidental renal mass in the octogenarian. World J Urol. 2017 Jul; 35 (7):1089-1094 Epub 2016 Nov 01
    View PubMed
  39. Gaunay GS, Patel V, Shah P, Moreira D, Rastinehad AR, Ben-Levi E, Villani R, Vira MA. Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy. Asian J Urol. 2017 Jan; 4 (1):31-36 Epub 2016 Nov 19
    View PubMed
  40. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. J Urol. 2016 Aug; 196 (2):327-34 Epub 2016 Feb 19
    View PubMed
  41. Leavitt DA, Keheila M, Siev M, Shah PH, Moreira DM, George AK, Salami SS, Schwartz MJ, Richstone L, Vira MA, Kavoussi LR. Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy. J Urol. 2016 Apr; 195 (4 Pt 1):859-64 Epub 2015 Oct 29
    View PubMed
  42. Shah PH, George AK, Moreira DM, Alom M, Okhunov Z, Salami S, Waingankar N, Schwartz MJ, Vira MA, Richstone L, Kavoussi LR. To clamp or not to clamp? Long-term functional outcomes for elective off-clamp laparoscopic partial nephrectomy. BJU Int. 2016 Feb; 117 (2):293-9 Epub 2015 Oct 01
    View PubMed
  43. Shah PH, Smith AT, Leavitt DA, Yaskiv O, Kavoussi LR. Ureteropelvic Junction Obstruction Secondary to Metastatic Relapse of Breast Cancer. Urol Case Rep. 2016 Jan; 4:38-40 Epub 2015 Oct 20
    View PubMed
  44. George AK, Rothwax JT, Herati AS, Srinivasan AK, Rais-Bahrami S, Shah P, Waingankar N, Saluja SS, Richstone L, Kavoussi LR. Perioperative Outcomes of Laparoscopic Partial Nephrectomy Stratified by Body Mass Index. J Endourol. 2015 Sep; 29 (9):1011-7 Epub 2015 July 13
    View PubMed
  45. Spettel S, Shah P, Sekhar K, Herr A, White MD. Using Hounsfield unit measurement and urine parameters to predict uric acid stones. Urology. 2013 Jul; 82 (1):22-6 Epub 2013 May 17
    View PubMed
  46. Mneimneh WS, Linos K, Shah P, Jennings TA, Fisher H, Nazeer T. Micropapillary carcinoma: new variant of prostatic acinar adenocarcinoma. Arch Pathol Lab Med. 2012 Nov; 136 (11):1447-50
    View PubMed